[The following is a paid advertisement.]

Illinois hospitals support transparency in House Bill 2371 SA 2—the Patient Access to Pharmacy Protection Act—even as rigorous audits performed regularly on 340B providers over decades do not support drugmaker claims that the federal program lacks transparency.

The current status quo of drugmakers restrictions on 340B discounts, contrary to federal law, is causing significant harm to low-income and uninsured patients who benefit from the federal program. Hospitals agree with additional transparency requirements in the 340B bill because of this program’s importance in providing patients with lifesaving healthcare services.

HB 2371 SA 2 requires covered entities to submit annual reports to the General Assembly that include:

• A copy of the covered entity’s annual 340B program recertification;
• The covered entity’s community benefits report, including the amount of charity care they provide;
• The number of claims for prescription drugs received under 340B;
• A description of any adverse 340B audit findings in the preceding year; and
• A description of the 340B program’s impact on patients and communities the covered entity serves.

SA 2 also prevents duplicate discounts via policy and requires a process to pay back drugmakers for any duplicate discount.

340B is a vital lifeline for hospitals serving vulnerable Illinoisans. Vote YES on HB 2371 SA 2 to protect access to care. Learn more.